We Offer Worldwide Shipping
Login Wishlist

9-O-Methyl-4-hydroxyboeravinone B

$1,120

  • Brand : BIOFRON

  • Catalogue Number : BN-B0383

  • Specification : 98%(HPLC)

  • CAS number : 333798-10-0

  • Formula : C18H14O7

  • Molecular Weight : 342.3

  • PUBCHEM ID : 487168

  • Volume : 5mg

Available on backorder

Quantity
Checkout Bulk Order?

Catalogue Number

BN-B0383

Analysis Method

HPLC,NMR,MS

Specification

98%(HPLC)

Storage

-20℃

Molecular Weight

342.3

Appearance

Powder

Botanical Source

This product is isolated and purified from the herbs of Mirabilis jalapa

Structure Type

Flavonoids

Category

Standards;Natural Pytochemical;API

SMILES

CC1=C(C=C2C(=C1O)C(=O)C3=C(O2)C(OC4=C3C=CC=C4O)O)OC

Synonyms

[1]Benzopyrano[3,4-b][1]benzopyran-12(6H)-one, 4,6,11-trihydroxy-9-methoxy-10-methyl-/4,6,11-Trihydroxy-9-methoxy-10-methylchromeno[2,3-c]chromen-12-one/4,6,11-Trihydroxy-9-methoxy-10-methylchromeno[3,4-b]chromen-12(6H)-one

IUPAC Name

4,6,11-trihydroxy-9-methoxy-10-methyl-6H-chromeno[3,4-b]chromen-12-one

Density

1.6±0.1 g/cm3

Solubility

Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc.

Flash Point

251.8±25.0 °C

Boiling Point

672.9±55.0 °C at 760 mmHg

Melting Point

InChl

InChl Key

HTLOGFXLFFWJOX-UHFFFAOYSA-N

WGK Germany

RID/ADR

HS Code Reference

2933990000

Personal Projective Equipment

Correct Usage

For Reference Standard and R&D, Not for Human Use Directly.

Meta Tag

provides coniferyl ferulate(CAS#:333798-10-0) MSDS, density, melting point, boiling point, structure, formula, molecular weight etc. Articles of coniferyl ferulate are included as well.>> amp version: coniferyl ferulate

No Technical Documents Available For This Product.

PMID

23185724

Abstract

Objective
To describe inpatient course and length of hospital stay (LOS) for people who sustain brain disorders nationwide.

Method
We interviewed 1,903 randomly selected community-dwelling patients registered as ‘disabled by brain disorders’ in 28 regions of South Korea.

Results
Seventy-seven percent were initially admitted to a Western medicine hospital, and 18% were admitted to a traditional Oriental medicine hospital. Forty-three percent were admitted to two or more hospitals. Mean LOS was 192 days. Most patients stayed in one hospital for more than 4 weeks. The transfer rate to other hospitals was 30-40%. Repeated admissions and increased LOS were related to younger onset age, higher education, non-family caregiver employment, smaller families, and more severe disability.

Conclusion
Korean patients with brain disorders showed significantly prolonged LOS and repeated admissions. Factors increasing burden of care influenced LOS significantly.

KEYWORDS

Inpatients, Length of stay, Discharge, Stroke, Brain diseases

Title

Inpatient Course and Length of Hospital Stay in Patients with Brain Disorders in South Korea: A Population-based Registry Study

Author

Se Hee Jung, M.D., Ph.D., Kyoung Moo Lee, M.D., Ph.D.,1 Si-Woon Park, M.D.,2 Min Ho Chun, M.D., Ph.D.,3 Han Young Jung, M.D., Ph.D.,4 Il-soo Kim, M.D.,5 Se Hyun Kim, Ph.D.,6 and Tai Ryoon Han, M.D., Ph.D.corresponding author7

Publish date

2012 Oct;


Description :

Empty ...